Avita Medical Inc (RCEL)

Cost of Revenue

$3.94M

Quarterly · Period ending: · USD

RCEL logo

RCEL Cost of Revenue

Latest reported$3.94M
RCEL Quarterly Cost of Revenue ($195.39K → $3.94M)
High-resolution chart · PNG

RCEL cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Avita Medical Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
3,935,000
3,523,000
3,305,000
3,187,000
3,469,000
2,833,000
2,280,000
3,190,000
2,111,000
1,513,000
1,796,000
2,113,000
2,204,000
1,667,000
1,347,000
1,530,000
1,386,000
1,778,000
817,000
1,088,000
2,053,000
2,146,000
821,000
929,000
874,000
1,044,018
1,201,162
1,361,925
619,397
610,058
259,982
285,164
351,523
123,506
134,298
132,236
139,230
138,679
114,234
114,000
96,330
96,868
104,162
104,169
77,514
76,845
64,705
67,933
165,805
165,521
152,580
169,167
157,894
159,014
179,982
171,820
200,677
195,393
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.